Clinical Trial Update: First Time in Human Study With GSK1018921 [Phase 1]

View source ↗

Summary

First-in-human Phase 1 study of GSK1018921 in schizophrenia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• GSK1018921

Snippet

Sponsor: GlaxoSmithKline | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED